Trial Profile
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Fibromyalgia
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly and Company
- 16 Sep 2018 Results presented at the 17th World Congress on Pain
- 18 Jan 2018 Status changed from active, no longer recruiting to completed.
- 12 Jul 2017 Status changed from recruiting to active, no longer recruiting.